Allergan (AGN) to Report Q4 Earnings: What's in the Cards?While Allergan’s (AGN) Q4 sales are likely to be driven by new as well as established products like Botox and international growth, generic competition for some key products will hurt sales.


Read More At Article Source | Article Attribution